Organogenesis Holdings Inc (ORGO) Hedge Fund & Institutional Holdings (Q2 2026)

ORGO ranks #3932 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ORGO is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

135 institutions disclose a position in ORGO, but none treat it as a major bet — even Soleus Capital Management, L.P., its most concentrated holder, allocates just 0.8% of its own portfolio to it.

Farther Finance Advisors, LLC has added to its ORGO position for two straight quarters, increasing it by $94.4K to reach $142.3K today.

Jane Street Group, LLC has trimmed its ORGO position for two straight quarters, cutting it by $4.6M while still holding $75.6K.

ORGO is up 0.6% today, and institutions have been net buyers of $22.5M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

ORGO reported a net loss of $84.2M over the trailing twelve months.

• Not yet profitable — net loss of $84.2M over the trailing twelve months
• Revenue grew 6.5% year over year
• Net income declined year over year, from -$8.2M to -$84.2M
• Operating cash flow was negative, using $10.3M in cash
• Current ratio of 3.62x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.55x equity — within a conventional range